论文部分内容阅读
本研究回顾分析了 32例经拉米夫定治疗病人 ,将他们的年龄、性别、可能的感染途径、治疗前血清谷丙转氨酶、HBVDNA的水平、服药时间和停药时治疗结果作为可能的复发相关危险因素进行评估并对复发可能的原因进行分析。1 临床分析所有病人均为 2 0 0 0 - 0 6～ 2 0 0 4 - 0 1中
This study retrospectively analyzed 32 patients treated with lamivudine and analyzed their age, gender, possible routes of infection, serum alanine aminotransferase levels before treatment, HBVDNA levels, duration of treatment, and outcome of discontinuation as possible relapse Related risk factors to assess and analyze the possible causes of recurrence. A clinical analysis of all patients were 2 0 0 0 - 0 6 ~ 2 0 0 4 - 0 1 in